Xirun P. Wan

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Persistent Low-Level hCG After Gestational Trophoblastic Neoplasia Remission: Treatment-Free Probability Stratified by Early hCG Course.

Persistent Low-Level hCG After Gestational Trophoblastic Neoplasia Remission: Treatment-Free Probability Stratified by Early hCG Course.

Journal: Cancers

Published: June 15, 2026

Development of a Machine Learning‑Based Prognostic Model for Intermediate Trophoblastic Tumors: A Single-Center Study With Web-Based Tool Implementation.

Development of a Machine Learning‑Based Prognostic Model for Intermediate Trophoblastic Tumors: A Single-Center Study With Web-Based Tool Implementation.

Journal: JCO precision oncology

Published: June 12, 2026

Longitudinal AMH trajectories, ovarian reserve recovery, and fertility outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia: A real-world cohort study.

Longitudinal AMH trajectories, ovarian reserve recovery, and fertility outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia: A real-world cohort study.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: March 18, 2026

Comprehensive Analysis and Prognostic Modeling of Epithelioid Trophoblastic Tumor.

Comprehensive Analysis and Prognostic Modeling of Epithelioid Trophoblastic Tumor.

Journal: Obstetrics and gynecology

Published: July 10, 2025

Pretreatment circulating tumor DNA and tissue genomic profiling concordance in ovarian cancer: a prospective observational study of influencing factors and clinical implications.

Pretreatment circulating tumor DNA and tissue genomic profiling concordance in ovarian cancer: a prospective observational study of influencing factors and clinical implications.

Journal: Therapeutic advances in medical oncology

Published: July 01, 2025

Four-year complete remission with reduced-dose PARP inhibitor in advanced-stage epithelial ovarian cancer harboring a BRCA1 mutation: a case report of a chemotherapy-intolerant patient with idiopathic thrombocytopenic purpura.

Four-year complete remission with reduced-dose PARP inhibitor in advanced-stage epithelial ovarian cancer harboring a BRCA1 mutation: a case report of a chemotherapy-intolerant patient with idiopathic thrombocytopenic purpura.

Journal: Journal of ovarian research

Published: June 24, 2025

LINS: A general medical Q&A framework for enhancing the quality and credibility of LLM-generated responses.

LINS: A general medical Q&A framework for enhancing the quality and credibility of LLM-generated responses.

Journal: Nature communications

Published: March 23, 2025

The necessity of adjuvant surgery for patients with high-risk chemorefractory or relapsed gestational choriocarcinoma with complete remission after anti-PD-1 therapy.

The necessity of adjuvant surgery for patients with high-risk chemorefractory or relapsed gestational choriocarcinoma with complete remission after anti-PD-1 therapy.

Journal: Journal of gynecologic oncology

Published: December 12, 2024

Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study.

Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 29, 2024

Clinicopathological characteristics and oncologic outcomes of patients with gestational trophoblastic neoplasia manifesting as isolated pulmonary lesions.

Clinicopathological characteristics and oncologic outcomes of patients with gestational trophoblastic neoplasia manifesting as isolated pulmonary lesions.

Journal: Gynecologic oncology

Published: May 23, 2024

Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study.

Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 24, 2024

Impact of peri-operative venous thromboembolism on survival in patients with endometrial clear cell carcinoma: A 10-year single-institution retrospective study.

Impact of peri-operative venous thromboembolism on survival in patients with endometrial clear cell carcinoma: A 10-year single-institution retrospective study.

Journal: Chinese medical journal

Published: September 19, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026